Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061597

SVP & Chief Accounting Officer returned 5,289 shares (to the company)

  • SVP & Chief Accounting Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2017-11-15 Grant or award +15,000 65,838 D: show line 1 in the form
Thomsen Jillian B. SVP & Chief Accounting Officer 2017-11-16 Returned to the company −5,289 $44.23 $233,932 60,549 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2017-11-15 Grant or award · Stock Option +37,500 37,500 D: show line 3 in the form
Loading xslF345X03/doc4.xml…